grab the latest..
Whitepapers
The JP Morgan 2025 story - Key Trends in 2024 and Expectations for 2025
- Continued interest in Antibody-Drug Conjugates
- Focus on RNA-Based Therapeutics despite the collapse of the COVID market
- Emphasis on Rare Diseases
TNBC – Molecular subtypes & current SoC
An emerging class of therapies but facing setbacks
Current Development
Discover the process of development, manufacturing, and mitigation of challenges associated with mRNA vaccines
Latest whitepapers
Swissmedic 2023 insights
2023 insights into Swissmedic authorization of human medicinal products featuring a new active substance and additional indications
EMA
2023 Highlights of European Medicines Agency's human medications recommendations.
FDA
What's in store for 2024?
ASCO GU
Do these data change practice?
ASCO GI
Practice changing or more of the same
Upcoming Papers
Coming soon...
To receive an early preview, register with us.
Coming soon...
To receive an early preview, register with us.
Coming soon...
To receive an early preview, register with us.
